HK inno.N Corporation

195940 · KOSDAQ · South Korea

Public Market Listing

195940KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for HK inno.N Corporation are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(4 total)
4Total Assets
0Approved
3Phase 3 / Filed
1Phase 1–2 / Early
4Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
Phase 3
Angiotensin II receptor / Calcium channel / HMG-CoA reductaseSmall molecule
Atherosclerotic Cardiovascular Disease
Phase 3
Angiotensin II receptor / Calcium channel / HMG-CoA reductaseSmall molecule
Hypertension
AST-120(Kremezin)
Phase 3
Oral spherical carbon adsorbentSmall molecule
Chronic Kidney Disease
Phase 2
JAK1Small molecule
Atopic Dermatitis

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (1 year)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$748M———report ↗